Literature

Search Literature

You can search and request for digital copy(ies) of literature listed below. Your request will be processed within 5-10 business days. (You need to log in to request literature copies.) To read the abstracts, click on the DOI Link button.

Keyword

Filter by Protein Type

Filter by Contents

Filter by Products

You need to log in to request literature copies.

Select the literature you wish to request a copy of. To read the abstracts, click on teh DOI Link button.

41 Results Found

  1. 10
  2. 20
  3. 30
  4. All

  1. Large-scale production and properties of human plasma-derived activated Factor VII concentrate

    DOI Link
    Author
    Tomokiyo, K., et al.
    		 Organization
    Kaketsuken
    Journal
    Vox Sanguinis 84: 54-64
    		 Year
    2003
    Access
    Abstract Only

  2. In vitro study of a triple-secured von Willebrand factor concentrate

    DOI Link
    Author
    Mazurier, C., et al.
    		 Organization
    Laboratoire Francais du Franctionnement et des Biotechnologies
    Journal
    Vox Sanguinis 86: 100-104
    		 Year
    2004
    Access
    Abstract Only

  3. Implementation of a 20-nm pore-size filter in the plasma-derived Factor VIII manufacturing process

    DOI Link
    Author
    Furuya, K., et al.
    		 Organization
    Japanese Red Cross Plasma Fractionation Center
    Journal
    Vox Sanguinis 91: 119-125
    		 Year
    2006
    Access
    Abstract Only

  4. Removal of small nonenveloped viruses by antibody-enhanced nanofiltration during the manufacture of plasma derivative

    DOI Link
    Author
    Kreil, T., et al.
    		 Organization
    Baxter BioScience
    Journal
    Transfusion 46: 1143-1151
    		 Year
    2006
    Access
    Abstract Only

  5. Removal of small viruses (parvovirus) from IgG solution by virus removal filter Planova™ 20N

    DOI Link
    Author
    Hongo, T., et al.
    		 Organization
    Asahi Kasei Medical Co., Ltd. and Yamaguchi University
    Journal
    Journal of Membrane Science 278: 3-9
    		 Year
    2006
    Access
    Abstract Only

  6. A new liquid intravenous immunoglobulin with three dedicated virus reduction steps: virus and prion reduction capacity

    DOI Link
    Author
    Poelsler, G., et al.
    		 Organization
    Baxter Bioscience
    Journal
    Vox Sanguinis 94: 184-192
    		 Year
    2008
    Access
    Abstract Only

  7. Flebogamma® 5% DIF development: rationale for a new option in intravenous immunoglobulin therapy

    DOI Link
    Author
    Jorquera, J. I.
    		 Organization
    Institute Grifols S.A.
    Journal
    Clinical and Experimental Immunology 157: 17-21
    		 Year
    2009
    Access
    Open

  8. Effect of antibody solution conditions on filter performance for virus removal filter Planova™ 20N

    DOI Link
    Author
    Hongo-Hirasaki, T., et al.
    		 Organization
    Asahi Kasei Medical Co., Ltd.
    Journal
    Biotechnology Progress 26: 1080-1087
    		 Year
    2011
    Access
    Abstract Only

  9. Effects of varying virus-spiking conditions on a virus-removal filter Planova™ 20N in a virus validation study of antibody solutions

    DOI Link
    Author
    Hongo-Hirasaki, T., et al.
    		 Organization
    Asahi Kasei Medical Co., Ltd.
    Journal
    Biotechnology Progress 27: 162-169
    		 Year
    2011
    Access
    Abstract Only

  10. Effective virus inactivation and removal by steps of Biotest Pharmaceuticals IGIV production process

    DOI Link
    Author
    Dichtelmuller H. O., et al.
    		 Organization
    Biotest AG and Biotest Pharmaceuticals
    Journal
    Results in Immunology 2: 19-24
    		 Year
    2012
    Access
    Open

  11. Virus filtration of high-concentration monoclonal antibody solutions

    DOI Link
    Author
    Marques, B., et al.
    		 Organization
    Merck and Co., Inc.
    Journal
    Biotechnology Progress 25: 483-491
    		 Year
    2009
    Access
    Abstract Only
Previous